ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651605 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651605; 2) Community: the network communities that were significantly associated with the response to NSC 651605; 3) Molecule: the relationships between components within communities and NSC 651605; 4) MDR: the compounds that were significantly associated with the NSC 651605.

NSC Compound Enrichment Correlation
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0139796580235794 0.21880733
NSC 363812 Tetraplatin 0.0139796580235794 0.23153064
NSC 38643 Lenamycin 0.0139796580235794 0.25351771
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0139796580235794 0.077184519
NSC 641536 Quinoline-3-carboxylic acid, 6-chloro-4-phenyl- 2-[(piperazin-1-yl)methyl]-, ethyl ester 0.0139796580235794 0.15463579
NSC 644902 Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 0.0139796580235794 -0.037207298
NSC 645351 [Bis(aminomethyl)diethylsilane]dichloroplatinum (II) 0.0139796580235794 0.43929168
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0147237897640499 0.24086524
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.0147237897640499 0.35829649
NSC 237020 TA 1067 0.0147237897640499 0.41782412
Total:140  Current:57    [First] [Prev] [Next] [Last]